SCHEMBL25848290

SCHEMBL25848290

C=C(C)C(=O)OC1CCC(Oc2ccc3cc(-c4ccc(CCCCC)cc4OC(F)(F)F)c(=O)oc3c2)C1(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.33
NPC1 O15118 4/20 0.32
RAB9A P51151 4/20 0.32
MAOA P21397 2/20 0.32
MAOB P27338 2/20 0.32
KDM4E B2RXH2 2/20 0.32
GLA P06280 2/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
NOD2 Q9HC29 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
ACHE P22303 1/20 0.31
BACE1 P56817 1/20 0.31
TERT O14746 2/20 0.30
PTPN7 P35236 1/20 0.30
S1PR1 P21453 1/20 0.30
S1PR3 Q99500 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625305 0.93 STS (0.33) STSNPC1RAB9AMAOAMAOB
SCHEMBL25848292 0.92 KDM4E (0.38) NPC1RAB9AMAOAMAOBKDM4E
SCHEMBL25848288 0.90 THRB (0.37) STSNPC1RAB9AMAOAMAOB
SCHEMBL25855295 0.90 STS (0.34) STSNPC1RAB9AMAOAMAOB
SCHEMBL25848281 0.89 NPC1 (0.35) STSNPC1RAB9AMAOAMAOB
SCHEMBL25848285 0.89 MAOB (0.36) NPC1RAB9AMAOAMAOBKDM4E
SCHEMBL22625059 0.88 KDM4E (0.36) NPC1RAB9AMAOAMAOBKDM4E
SCHEMBL25848303 0.87 MAOB (0.38) NPC1RAB9AMAOAMAOBKDM4E
SCHEMBL22624935 0.87 STS (0.34) STSNPC1RAB9AMAOAMAOB
SCHEMBL25848266 0.87 STS (0.34) STSNPC1RAB9AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 STS 4081/4885NPC1 1051/4885RAB9A 1916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.